NewsOK Local Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Angiodynamics Inc (NQ: ANGO)
19.52 USD  -0.09 (-0.46%)
Streaming Delayed Price  /  Updated: 1:27 PM EDT, Jun 20, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 43,994
Open 19.82
Bid (Size) 19.50 (2)
Ask (Size) 19.53 (3)
Prev. Close 19.61
Today's Range 19.32 - 19.90
52wk Range 18.11 - 25.48
Shares Outstanding 36,804,506
Dividend Yield N/A
Performance
YTD
-1.41%
-1.41%
1 Month
+1.04%
+1.04%
3 Month
-11.83%
-11.83%
6 Month
-3.13%
-3.13%
1 Year
-11.63%
-11.63%
Top News
More News
AngioDynamics to Present at the Raymond James Life Sciences and MedTech Conference
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim... Read More
from Business Wire News Releases
AngioDynamics Completes Sale of NAMIC® Fluid Management Portfolio to Medline Industries, Inc.
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it closed... Read More
from Business Wire News Releases
More News
Read More
AngioDynamics to Ring NASDAQ Closing Bell to Celebrate the 15th Anniversary of its Listing on the Exchange
from Business Wire News Releases
AngioDynamics Receives FDA Approval to Initiate Pilot Study for the Use of NanoKnife® to Treat Prostate Cancer
from Business Wire News Releases
AngioDynamics Announces First Patient Enrolled in NanoKnife® DIRECT Clinical Study for the Treatment of Stage III Pancreatic Cancer
from Business Wire News Releases
Report: Developing Opportunities within 22nd Century Group, Darling Ingredients, Silvercorp Metals, Trevena, Star Bulk Carriers, and AngioDynamics — Future Expectations, Projections Moving into 2019
from GlobeNewswire News Releases
AngioDynamics Announces Agreement to Sell NAMIC® Fluid Management Business to Medline Industries, Inc. for $167.5 Million
from Business Wire News Releases
Analysts See 11% Gains Ahead For The Holdings of IEHS
category ETFs
from ETF Channel
AngioDynamics’ DIRECT Clinical Study Receives Institutional Review Board Approval for the Treatment of Stage III Pancreatic Cancer
from Business Wire News Releases
Relative Strength Alert For AngioDynamics
category Stocks
from Market News Video
Implied VIOG Analyst Target Price: $173
category ETFs
from ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.